The author reflects on role of bronchoalveolar lavage (BAL) lymphocytosis in the evaluation of patients with fibrotic interstitial lung disease (ILD) and key questions addressed in a recent clinical practice guideline focused on the diagnosis of hypersensitivity pneumonitis (HP). It mentions area under the receiver-operating-characteristic curve (AUC) would suggest the contradictory conclusion that using BAL lymphocytosis to distinguish fibrotic HP from idiopathic pulmonary fibrosis (IPF).